Adult Soft Tissue Sarcoma: Diagnosis and Care
Adult soft tissue sarcoma: diagnosis, care, safety and funding.
Independent, primary-sourced research on cancer prevention and supplement claims — evidence graded honestly, with industry funding and conflicts disclosed.
Adult soft tissue sarcoma: diagnosis, care, safety and funding.
Adult MDS: diagnosis, care, classification and source funding.
DCIS remains inside breast ducts without invasion; NCI calls it technically not cancer. Definition. Confidence: high for identity; independent outcomes remain unresolved. Key takeawaysBiopsy and pathology establish the diagnosis; a scan alone does not establish invasion. Diagnosis.Lumpectomy and mastectomy address different local circumstances. Care options.Node assessment differs between breast-conserving surgery and mastectomy. NICE.COMET studied selected … Read more
Hydroxycarbamide (hydroxyurea) is prescription-only. Ingredient identity. Key takeawaysExact-product instructions matter.Report infection or bleeding.Licences differ. Table of contentsEvidence summaryProductsMechanismsTreatment monitoringSupplementsEvidence and prescribingUrgent careInteractionsReproductive precautionsHandlingPreclinical limitsFunding and source rolesFrequently asked questionsSources and funding notes Evidence summary Clinical descriptions, care guidance and independently established treatment outcomes have different evidentiary roles. The table identifies what the reviewed sources can … Read more
Adult adrenal-cortex cancer: specialist care, safety and research funding, with evidence limits.
Solitary plasmacytoma: assessment and safety.
Merkel cell carcinoma: symptoms, biopsy and staging, care choices, urgent warnings and source funding.
Salivary cancer: diagnosis and nerve risks.
Lower-throat cancer: care, funding.
Nasopharyngeal cancer: tests, care and funding.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.